BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 12843212)

  • 1. Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson's disease patients.
    Huang WS; Chiang YH; Lin JC; Chou YH; Cheng CY; Liu RS
    J Nucl Med; 2003 Jul; 44(7):999-1005. PubMed ID: 12843212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity and specificity of 99mTc-TRODAT-1 SPECT imaging in differentiating patients with idiopathic Parkinson's disease from healthy subjects.
    Weng YH; Yen TC; Chen MC; Kao PF; Tzen KY; Chen RS; Wey SP; Ting G; Lu CS
    J Nucl Med; 2004 Mar; 45(3):393-401. PubMed ID: 15001678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 99mTc-TRODAT-1 imaging of multiple system atrophy.
    Lu CS; Weng YH; Chen MC; Chen RS; Tzen KY; Wey SP; Ting G; Chang HC; Yen TC
    J Nucl Med; 2004 Jan; 45(1):49-55. PubMed ID: 14734673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of early-stage Parkinson's disease with 99mTc-TRODAT-1 imaging.
    Huang WS; Lin SZ; Lin JC; Wey SP; Ting G; Liu RS
    J Nucl Med; 2001 Sep; 42(9):1303-8. PubMed ID: 11535717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 99mTc-TRODAT-1 SPECT and 18 F-AV-133 PET imaging in healthy controls and Parkinson's disease patients.
    Hsiao IT; Weng YH; Lin WY; Hsieh CJ; Wey SP; Yen TC; Kung MP; Lu CS; Lin KJ
    Nucl Med Biol; 2014 Apr; 41(4):322-9. PubMed ID: 24503330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 99mTc-TRODAT-1 SPECT in healthy and 6-OHDA lesioned parkinsonian monkeys: comparison with 18F-FDOPA PET.
    Huang WS; Ma KH; Chou YH; Chen CY; Liu RS; Liu JC
    Nucl Med Commun; 2003 Jan; 24(1):77-83. PubMed ID: 12501023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the role of 99mTc-TRODAT-1 SPECT imaging in idiopathic Parkinson's disease.
    Geng Y; Shi GH; Jiang Y; Xu LX; Hu XY; Shao YQ
    J Zhejiang Univ Sci B; 2005 Jan; 6(1):22-7. PubMed ID: 15593387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Performance of 99mTc-TRODAT-1 SPECT/CT and 18F-FDOPA PET/CT Imaging in Patients With Parkinson's Disease, Parkinson-Plus Syndrome, and Essential Tremor.
    Sood A; Shukla J; Shree R; Vatsa R; Modi M; Mittal BR
    Clin Nucl Med; 2021 Feb; 46(2):95-102. PubMed ID: 33234920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducibility of 99mTc-TRODAT-1 SPECT measurement of dopamine transporters in Parkinson's disease.
    Hwang WJ; Yao WJ; Wey SP; Ting G
    J Nucl Med; 2004 Feb; 45(2):207-13. PubMed ID: 14960637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine transporter concentration is reduced in asymptomatic Machado-Joseph disease gene carriers.
    Yen TC; Tzen KY; Chen MC; Chou YH; Chen RS; Chen CJ; Wey SP; Ting G; Lu CS
    J Nucl Med; 2002 Feb; 43(2):153-9. PubMed ID: 11850478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging early-stage corticobasal degeneration with [99mTc]TRODAT-1 SPET.
    Lai SC; Weng YH; Yen TC; Tsai CC; Chang HC; Wey SP; Ting G; Lu CS
    Nucl Med Commun; 2004 Apr; 25(4):339-45. PubMed ID: 15097807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential diagnosis of Parkinson's disease and vascular parkinsonism by (99m)Tc-TRODAT-1.
    Tzen KY; Lu CS; Yen TC; Wey SP; Ting G
    J Nucl Med; 2001 Mar; 42(3):408-13. PubMed ID: 11337515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.
    Antonini A; Vontobel P; Psylla M; Günther I; Maguire PR; Missimer J; Leenders KL
    Arch Neurol; 1995 Dec; 52(12):1183-90. PubMed ID: 7492293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase 2, open-label, multi-center study to evaluate the efficacy and safety of
    Sun Y; Liu C; Chen Z; Li B; Lv Z; Lou J; Tang J; Wang Y; Zhang G; Liu X
    Ann Nucl Med; 2020 Jan; 34(1):31-37. PubMed ID: 31646428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease.
    Siderowf A; Newberg A; Chou KL; Lloyd M; Colcher A; Hurtig HI; Stern MB; Doty RL; Mozley PD; Wintering N; Duda JE; Weintraub D; Moberg PJ
    Neurology; 2005 May; 64(10):1716-20. PubMed ID: 15911797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease.
    Weintraub D; Newberg AB; Cary MS; Siderowf AD; Moberg PJ; Kleiner-Fisman G; Duda JE; Stern MB; Mozley D; Katz IR
    J Nucl Med; 2005 Feb; 46(2):227-32. PubMed ID: 15695780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.
    Ishikawa T; Dhawan V; Kazumata K; Chaly T; Mandel F; Neumeyer J; Margouleff C; Babchyck B; Zanzi I; Eidelberg D
    J Nucl Med; 1996 Nov; 37(11):1760-5. PubMed ID: 8917170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 99mTc-TRODAT-1 SPECT study in early Parkinson's disease and essential tremor.
    Wang J; Jiang YP; Liu XD; Chen ZP; Yang LQ; Liu CJ; Xiang JD; Su HL
    Acta Neurol Scand; 2005 Dec; 112(6):380-5. PubMed ID: 16281920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease.
    Lynch DR; Mozley PD; Sokol S; Maas NM; Balcer LJ; Siderowf AD
    Mov Disord; 2003 Jul; 18(7):804-12. PubMed ID: 12815660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [(18)F]FDOPA and [(18)F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease.
    Rinne OJ; Nurmi E; Ruottinen HM; Bergman J; Eskola O; Solin O
    Synapse; 2001 Jun; 40(3):193-200. PubMed ID: 11304757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.